ConductScience.org, home

Gene · 3623

INHA: inhibin subunit alpha

12 sourcesgene-search-2026-11-11-0.2.0

Download JSON
Cite this record

ConductScience Library. INHA: inhibin subunit alpha. Genes, record 3623. Release gene-search-2026-11-11-0.2.0, 11 Nov 2026. https://conductscience.org/library/genes/3623

On this page

Gene

Symbol
INHA
HGNC
Name
inhibin subunit alpha
HGNC
NCBI Gene ID
3623
NCBI Gene
HGNC ID
HGNC:6065
HGNC
Ensembl
ENSG00000123999
NCBI Gene
Type
protein-coding
NCBI Gene

Proteins1

Reviewed human proteins whose Swiss-Prot entry states the gene.

UniProt entryProteinLengthStructuresGene stated in
P05111Inhibin alpha chain3660Ensembl, GeneID, HGNC

Source UniProt

Patents63

Patents whose sequence listing contains this protein's exact sequence. A patent can list a sequence without claiming it.

PublicationPublishedSEQ ID NOProteinSource
EP 4705273 A22026-03-11184P05111Espacenet
JP 2026004568 A2026-01-1449745P05111Espacenet
EP 4650780 A22025-11-191101P05111Espacenet
JP 2025147176 A2025-10-067177P05111Espacenet
JP 2025529142 A2025-09-046753P05111Espacenet
US 12371689 B22025-07-296753P05111Espacenet
JP 2025517970 A2025-06-121101P05111Espacenet
JP 2025028984 A2025-03-054P05111Espacenet
JP 2025028160 A2025-02-287177P05111Espacenet
JP 2025013347 A2025-01-24184P05111Espacenet

1 to 10 of 63

See all 63 patents

Drugs0

Drugs a ChEMBL mechanism record says act on the gene's protein, through Open Targets.

None in this release.

Trials0

Trials of those drugs. A trial joins the gene only through a drug that acts on it.

None in this release.

NIH grants721

NIH grants whose papers are about the gene, through NIH's grant-paper links.

GrantTitleINHA papersNewest fiscal year
D43TW009127Ethiopia-Emory TB Research Training Program72025
P30AI036214San Diego Center for AIDS Research (SD CFAR)52025
UM1AI068632IMPAACT Leadership Group52025
UM1AI068634Statistical and Data Management Center (SDMC), Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections (ACTG)52025
UM1AI068636Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections52025
P30CA091842Cancer Center Support Grant42025
UL1TR002345Washington University Institute of Clinical and Translational Sciences42025
UM1AI106701AIDS Clinical Trial Group Laboratory Center42025
D43TW007124Emory-Georgia TB Research Training Program32025
P30CA016672Cancer Center Support Grant32025

1 to 10 of 721Source NIH's project files

See all 721 nih grants

Papers1,777

Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.

TitleJournalYearPMIDFound bySource
Drug resistance in patients with tuberculosis: a study from a tertiary care center in northern India.Monaldi Arch Chest Dis202642788205PubTator, text miningPubMed
Comprehensive genome-based characterization and pan-genome analysis of Bacillus paranthracis SM02 isolated from a fermented food ecosystem.Funct Integr Genomics202642776301PubTator, text miningPubMed
Exploration of novel indolo[2,3-b]quinoxaline hybrids as InhA inhibitors: A multi-disciplinary approach involving synthesis, antimycobacterial evaluation and computational studies.Eur J Med Chem202642767000PubTator, text miningPubMed
Design, Synthesis, Antimycobacterial Evaluation, and In Silico Investigation of Benzisothiazole-Based Hydrazide Derivatives as Potential Anti-Tuberculosis Agents.Chem Biol Drug Des202642760852PubTator, text miningPubMed
Multi-Omics Analysis of the Effects of INHA and FNDC1 on Clutch Length in Zi Geese.Int J Mol Sci202642589455PubTator, text miningPubMed
Genotypic Characterization of Drug Resistance-associated Mutations in Mycobacterium tuberculosis Using Line Probe Assays in Central India.Int J Mycobacteriol202642378606PubTator, text miningPubMed
Identification and functional validation of P4HA1 and INHA as hypoxia-responsive biomarkers in preeclampsia.Placenta202642302511PubTator, text miningPubMed
Research overview-2025: integrating scientific progress to accelerate global tuberculosis elimination.Front Tuberc202642267172PubTator, text miningPubMed
Influence of Diabetes Mellitus on the Development of Multidrug-Resistant Tuberculosis (MDR-TB) in Relation With Genetic Mutations of M. tuberculosis Isolates in Ethiopia.Can J Infect Dis Med Microbiol202642255943PubTator, text miningPubMed
Water-Soluble Inclusion Complexation of Naphthyl-Containing Thiosemicarbazides and Thioureas with β-Cyclodextrin.Molecules202642075968PubTator, text miningPubMed

1 to 10 of 1,777

See all 1,777 papers

Sources 12

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
  • GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
  • HGNCCC0
  • NCBI GenePublic domain (US government)
  • NIH's project files and grant-paper linksPublic domain
  • Open TargetsCC0 1.0
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
  • GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
  • HGNCCC0: https://www.genenames.org/about/license/
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this gene from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/genes/v1/3623

GET https://conductscience.org/api/genes/v1/3623/patents?page=2